Status:
COMPLETED
Change in Plaque Characteristics With Atorvastatin
Lead Sponsor:
Wakayama Medical University
Conditions:
Acute Coronary Syndrome
Atherosclerosis
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in patients with acute coronary syndrome.
Detailed Description
Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI and have at least one atherosclerotic lesion of \>25% stenosis other than culprit lesions of curre...
Eligibility Criteria
Inclusion
- Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI.
- plasma LDL cholesterol levels : \>=100mg/dL and ≤160mg/dL
- at least one atherosclerotic lesion of \>25% stenosis other than culprit lesions of current ACS
Exclusion
- Patients who will undergo coronary bypass surgery.
- Patients with major complications during treatment of culprit coronary lesions.
- Patients with an atherosclerotic lesion with \>50% stenosis at a left main trunk.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00700037
Start Date
August 1 2009
End Date
February 1 2012
Last Update
October 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wakayama Medical University
Wakayama, Wakayama, Japan, 641-8509